Showing results (301-310 of 422) with videos related to
Sort By:
Pageof 43
Cancer Chemotherapy and Pharmacology|February 13, 2015
Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcomaSandra P D' Angelo, Michelle R Mahoney, Brian A Van Tine, et al.The Journal of Clinical Investigation|May 15, 2023
Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastasesMark C Korpics, Benjamin E Onderdonk, Rebekah E Dadey, et al.The Journal of Clinical Investigation|April 15, 2010
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccineDavide Corti, Amorsolo L Suguitan, Debora Pinna, et al.Melanoma Research|September 14, 2018
Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanomaShalin Shah, Jason J Luke, Heather A Jacene, et al.Oncology|June 24, 2019
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid TumorsDavid Hong, Drew Rasco, Michael Veeder, et al.Cancers|April 27, 2024
Th2 Cells Are Associated with Tumor Recurrence Following RadiationMohamed K Abdelhakiem, Riyue Bao, Phillip M Pifer, et al.Cancer Immunology Research|April 12, 2017
Clinical Features of Acquired Resistance to Anti-PD-1 Therapy in Advanced MelanomaDaniel Y Wang, Zeynep Eroglu, Alpaslan Ozgun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 29, 2018
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)Tara C Mitchell, Omid Hamid, David C Smith, et al.Bone|June 12, 2024
Prkd1 regulates the formation and repair of plasma membrane disruptions (PMD) in osteocytesAnik Tuladhar, Joseph C Shaver, Wesley A McGee, et al.The Journal of Infectious Diseases|January 13, 2017
A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult VolunteersKristen K Pierce, Stephen S Whitehead, Beth D Kirkpatrick, et al.Pageof 43